David Fairlie
The University Of Queensland, QLD, Australia

David is Head of Chemistry and Structural Biology at the Institute for Molecular Bioscience, University of Queensland. He was educated at University of Adelaide, Australian National University, University of New South Wales, Stanford University and University of Toronto. He has continuously held ARC and NHMRC Fellowships since 2002 and consulted to and collaborated with numerous pharma companies worldwide. His research at chemistry-biology interfaces has focussed on design of small organic molecules that modulate enzymes, GPCRs, protein-protein interactions, cell signalling pathways, and on elucidating mechanisms of disease development, immune responses and drug action.
Presentations this author is a contributor to:
Identification of phenotypically and functionally heterogeneous mouse Mucosal Associated Invariant T cells using MR1 tetramers. (#116)
4:00 PM
Hui-Fern Koay
Poster Listing
Drugs/Drug analogues modulate MAIT cell function in an MR1-dependent manner (#98)
4:00 PM
Sidonia BG Eckle
Poster Listing
MR1-ligand induced apoptosis and functional impairment of mucosal associated invariant T (MAIT) cells in patients with rheumatoid arthritis and ankylosing spondylitis (#153)
4:00 PM
Ranjeny Thomas
Poster Listing
MR1, drugs and rock and roll (#36)
11:20 AM
Jamie Rossjohn
Session 5 - Antigen Recognition